Aditya Subhash Khanna1,2, Mert Edali3,4,5, Jonathan Ozik6, Nicholson Collier6, Anna Hotton3,4, Abigail Skwara3,4, Babak Mahdavi Ardestani3,4, Russell Brewer3,4, Kayo Fujimoto7, Nina Harawa8,9, John A Schneider3,4. 1. Center for Alcohol and Addiction Studies, Brown University, Providence RI, USA. 2. Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence RI, USA. 3. Chicago Center for HIV Elimination, The University of Chicago, Chicago, IL, USA. 4. Department of Medicine, The University of Chicago, Chicago, IL, USA. 5. Department of Industrial Engineering, Yildiz Technical University, Besiktas, Istanbul 34349, Turkey. 6. Decision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, IL, USA. 7. Center for Health Promotion and Prevention Research, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA. 8. Department of Psychiatry and Human Behavior, Charles R. Drew University, Los Angeles, CA, USA. 9. Department of Epidemiology, University of California, Los Angeles, CA, USA.
Abstract
OBJECTIVES: Getting to Zero (GTZ) initiatives focus on expanding use of antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) to eliminate new HIV infections. Computational models help inform policies for implementation of ART and PrEP continuums. Such models, however, vary in their design, and may yield inconsistent predictions. Using multiple approaches can help assess the consistency in results obtained from varied modeling frameworks, and can inform optimal implementation strategies. METHODS: A study using three different modeling approaches is conducted. Two approaches use statistical time series analysis techniques that incorporate temporal HIV incidence data. A third approach uses stochastic stimulation, conducted using an agent-based network model (ABNM). All three approaches are used to project HIV incidence among a key population, young Black MSM (YBMSM), over the course of the GTZ implementation period (2016-2030). RESULTS: All three approaches suggest that simultaneously increasing PrEP and ART uptake is likely to be more effective than increasing only one, but increasing ART and PrEP by 20% points may not eliminate new HIV infections among YBMSM. The results further suggest that a 20% increase in ART is likely to be more effective than a 20% increase in PrEP. All three methods consistently project that increasing ART and PrEP by 30% simultaneously can help reach GTZ goals. CONCLUSIONS: Increasing PrEP and ART uptake by about 30% might be necessary to accomplish GTZ goals. Such scale-up may require addressing psychosocial and structural barriers to engagement in HIV and PrEP care continuums. ABNMs and other flexible modeling approaches can be extended to examine specific interventions that address these barriers and may provide important data to guide the successful intervention implementation.
OBJECTIVES: Getting to Zero (GTZ) initiatives focus on expanding use of antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) to eliminate new HIV infections. Computational models help inform policies for implementation of ART and PrEP continuums. Such models, however, vary in their design, and may yield inconsistent predictions. Using multiple approaches can help assess the consistency in results obtained from varied modeling frameworks, and can inform optimal implementation strategies. METHODS: A study using three different modeling approaches is conducted. Two approaches use statistical time series analysis techniques that incorporate temporal HIV incidence data. A third approach uses stochastic stimulation, conducted using an agent-based network model (ABNM). All three approaches are used to project HIV incidence among a key population, young Black MSM (YBMSM), over the course of the GTZ implementation period (2016-2030). RESULTS: All three approaches suggest that simultaneously increasing PrEP and ART uptake is likely to be more effective than increasing only one, but increasing ART and PrEP by 20% points may not eliminate new HIV infections among YBMSM. The results further suggest that a 20% increase in ART is likely to be more effective than a 20% increase in PrEP. All three methods consistently project that increasing ART and PrEP by 30% simultaneously can help reach GTZ goals. CONCLUSIONS: Increasing PrEP and ART uptake by about 30% might be necessary to accomplish GTZ goals. Such scale-up may require addressing psychosocial and structural barriers to engagement in HIV and PrEP care continuums. ABNMs and other flexible modeling approaches can be extended to examine specific interventions that address these barriers and may provide important data to guide the successful intervention implementation.
Entities:
Keywords:
HIV infections ; computer simulation ; pre-exposure prophylaxis ; preventive medicine ; sexual and gender minorities
Authors: Laura K Rusie; Carlos Orengo; Diane Burrell; Arthi Ramachandran; Magda Houlberg; Kristin Keglovitz; David Munar; John A Schneider Journal: Clin Infect Dis Date: 2018-07-02 Impact factor: 9.079
Authors: C Hendricks Brown; David C Mohr; Carlos G Gallo; Christopher Mader; Lawrence Palinkas; Gina Wingood; Guillermo Prado; Sheppard G Kellam; Hilda Pantin; Jeanne Poduska; Robert Gibbons; John McManus; Mitsunori Ogihara; Thomas Valente; Fred Wulczyn; Sara Czaja; Geoff Sutcliffe; Juan Villamar; Christopher Jacobs Journal: J Acquir Immune Defic Syndr Date: 2013-06-01 Impact factor: 3.731
Authors: Alexandra Jones; Ide Cremin; Fareed Abdullah; John Idoko; Peter Cherutich; Nduku Kilonzo; Helen Rees; Timothy Hallett; Kevin O'Reilly; Florence Koechlin; Bernhard Schwartlander; Barbara de Zalduondo; Susan Kim; Jonathan Jay; Jacqueline Huh; Peter Piot; Mark Dybul Journal: Lancet Date: 2014-04-14 Impact factor: 79.321
Authors: Francis Lee; Daniel Sheeler; Anna Hotton; Natascha Del Vecchio; Rey Flores; Kayo Fujimoto; Nina Harawa; John A Schneider; Aditya S Khanna Journal: Int J Drug Policy Date: 2022-02-24
Authors: Adrien Le Guillou; Susan Buchbinder; Hyman Scott; Albert Liu; Diane Havlir; Susan Scheer; Samuel M Jenness Journal: J Acquir Immune Defic Syndr Date: 2021-12-01 Impact factor: 3.771